The ESGO/ESTRO/ESP 2021 guidelines define four molecular subtypes of endometrial carcinoma: POLE ultramutated, mismatch repair deficient (MMRd), p53-aberrant, and NSMP (no specific molecular profile) [10]. This evidence concerns the gene TP53 and endometrial carcinoma.